e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Aptevo Therapeutics Inc. - Common Stock
(NQ:
APVO
)
9.390
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 30, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Aptevo Therapeutics Inc. - Common Stock
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Aptevo Therapeutics Reports 3Q23 Financial Results and Provides a Business Update
November 14, 2023
Via
ACCESSWIRE
Why Wynn Resorts Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
November 10, 2023
Shares of Wynn Resorts, Limited (NASDAQ: WYNN) fell sharply on Friday after the company reported third-quarter financial results.
Via
Benzinga
Aptevo Therapeutics Reports 2Q23 Financial Results and Provides a Business Update
August 10, 2023
Via
ACCESSWIRE
Why Direct Digital Shares Are Trading Higher By Around 33%; Here Are 20 Stocks Moving Premarket
↗
November 10, 2023
Shares of Direct Digital Holdings, Inc. (NASDAQ: DRCT) rose sharply in pre-market trading after the company reported better-than-expected third-quarter financial results.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
November 10, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
↗
November 10, 2023
We're closing out the trading week with a breakdown of the biggest pre-market stock movers worth watching for Friday morning!
Via
InvestorPlace
Aptevo to Present at Bio-Europe Conference
November 01, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Monday's After-Market Session
↗
September 11, 2023
Via
Benzinga
Why Delcath Systems Shares Are Trading Higher By Around 58%; Here Are 20 Stocks Moving Premarket
↗
August 15, 2023
Gainers Delcath Systems, Inc. (NASDAQ: DCTH) shares surged 57.7% to $4.93 in pre-market trading after the company reported the FDA approval of HEPZATO KIT™ for the treatment of adult patients with...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
↗
August 15, 2023
Pre-market stock movers are a hot topic with investors this morning and we're checking out the biggest ones worth watching on Tuesday!
Via
InvestorPlace
Aptevo Therapeutics Inc. Announces Closing of Previously Announced $5 Million Public Offering
August 04, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
August 02, 2023
Via
Benzinga
Why Aptevo Therapeutics Stock Is Getting Obliterated
↗
August 02, 2023
Aptevo Therapeutics Inc (NASDAQ: APVO) shares are trading lower by after the company priced its $5 million public offering of 8,064,517 shares at 62 cents per share.
Via
Benzinga
Is AMD Stock the Next Big AI Play?
↗
August 02, 2023
Advanced Micro Devices (AMD) stock is in the news Wednesday as investors wonder if the tech company can succeed in the AI market!
Via
InvestorPlace
MTCH Stock Price Prediction: Can Match Group Rally 30% From Here?
↗
August 02, 2023
Match Group (MTCH) stock is on the move Wednesday after getting a new price prediction and rating from BTIG analyst Jake Fuller.
Via
InvestorPlace
Why Exact Sciences Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
August 02, 2023
Gainers WaveDancer, Inc. (NASDAQ: WAVD) shares climbed 86% to $0.5505. Tellenger, a subsidiary of Wavedancer, Inc., won a seven-year U.S. government contract.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
August 02, 2023
Via
Benzinga
Why Is Aptevo Therapeutics (APVO) Stock Down 33% Today?
↗
August 02, 2023
Aptevo Therapeutics (APVO) stock is sliding lower on Wednesday after the biotechnology company announced a public share offering.
Via
InvestorPlace
Why Rover Group Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
↗
August 02, 2023
Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares surged 52.1% to $0.1049 in pre-market trading.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
↗
August 02, 2023
It's time for another breakdown of the biggest pre-market stock movers as we check out all of the latest news for Wednesday!
Via
InvestorPlace
Aptevo Therapeutics Inc. Announces Pricing of $5 Million Public Offering
August 01, 2023
Via
ACCESSWIRE
7 Millionaire-Maker Penny Stocks to Buy Before the Window Closes
↗
July 30, 2023
Although speculative trades are not for everyone, these millionaire-maker penny stocks could turn small bets into big returns.
Via
InvestorPlace
5 Value Stocks In The Healthcare Sector
↗
July 24, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
July 20, 2023
Via
Benzinga
Why Amarin Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
July 19, 2023
Gainers Biodexa Pharmaceuticals Plc (NASDAQ: BDRX) rose 43% to $6.91.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
July 19, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
July 18, 2023
Via
Benzinga
Why Lixte Biotechnology Shares Are Trading Lower By 26%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
July 18, 2023
Gainers Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) gained 90% to $0.3560 after the company issued strategic update and announced restructuring.
Via
Benzinga
Aptevo Therapeutics Stock Is Sinking Today - Here's Why
↗
July 18, 2023
Aptevo Therapeutics Inc (NASDAQ: APVO) announced that its bispecific acute myelogenous leukemia (AML) drug candidate APVO436, in combination with venetoclax and azacitidine, achieved positive duration...
Via
Benzinga
Aptevo Announces Positive Duration of Remission Data from Phase 1b Expansion Trial Evaluating the Bispecific APVO436 for AML
July 18, 2023
Via
ACCESSWIRE
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.